申请人:Nippon Shinyaku Co., Ltd.
公开号:US05089529A1
公开(公告)日:1992-02-18
4-mono- and di-isobutylamino butanols of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.1 and R.sup.2 are the same or different and each is selected from the group consisting of hydrogen, halo, hydroxyl, alkyl of 1 to 4 carbon atoms and alkoxy of 1 to 4 carbon atoms and R is hydrogen or isobutyl, are useful for the treatment of circulatory disorders, particularly arrhythmias, in humans and animals.
公式(I)中的4-单烷基和二烷基氨基丁醇:##STR1##或其药学上可接受的盐,其中R^1和R^2相同或不同,并且每个都是从氢,卤素,羟基,1到4个碳原子的烷基和1到4个碳原子的烷氧基的群中选择的,而R是氢或异丁基。它们对于治疗人和动物的循环障碍,特别是心律失常,是有用的。